Evolus, Inc.
US ˙ NasdaqGM ˙ US30052C1071

SecurityEOLS / Evolus, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Qube Research & Technologies Ltd closes position in EOLS / Evolus, Inc.

On February 17, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 0 shares of Evolus, Inc. (US:EOLS) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 177,693 shares of Evolus, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F EVOLUS COM 30052C107 0 -100.00 0
2025-11-14 2025-09-30 13F EVOLUS COM 30052C107 177,693 -548,505 -75.53 1,091 -83.69 0.0011
2025-08-14 2025-06-30 13F EVOLUS COM 30052C107 726,198 -55,350 -7.08 6,688 -28.87 0.0068
2025-05-15 2025-03-31 13F EVOLUS COM 30052C107 781,548 27,469 3.64 9,402 12.94 0.0109
2025-02-14 2024-12-31 13F EVOLUS COM 30052C107 754,079 187,031 32.98 8,325 -9.37 0.0109
2024-11-14 2024-09-30 13F EVOLUS COM 30052C107 567,048 40,431 7.68 9,186 60.79 0.0135
2024-08-14 2024-06-30 13F EVOLUS COM 30052C107 526,617 258,672 96.54 5,714 52.31 0.0090
2024-05-14 2024-03-31 13F EVOLUS COM 30052C107 267,945 221,853 481.33 3,751 673.40 0.0059
2024-02-13 2023-12-31 13F EVOLUS COM 30052C107 46,092 36,260 368.80 485 444.94 0.0009
2023-11-13 2023-09-30 13F EVOLUS COM 30052C107 9,832 -1,165 -10.59 90 12.66 0.0002
2023-08-14 2023-06-30 13F EVOLUS COM 30052C107 10,997 10,997 80 0.0003
2023-02-14 2022-12-31 13F EVOLUS COM 30052C107 0 -16,982 -100.00 0 -100.00
2022-11-14 2022-09-30 13F EVOLUS COM 30052C107 16,982 16,982 137 0.0008
2022-02-10 2021-12-31 13F/A-1 EVOLUS COM 30052C107 0 -44,207 -100.00 0 -100.00
2022-02-01 2021-12-31 13F EVOLUS COM 30052C107 0 -44,207 0
2021-11-12 2021-09-30 13F EVOLUS COM 30052C107 44,207 30,600 224.88 337 95.93 0.0042
2021-08-13 2021-06-30 13F EVOLUS COM 30052C107 13,607 13,607 172 0.0020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.